|
|
Volumn 8, Issue 3, 2002, Pages 224-226
|
|
Serologic tests are helpful in managing inflammatory bowel disease
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
BIOLOGICAL MARKER;
DRUG METABOLITE;
FUNGUS ANTIBODY;
INFLIXIMAB;
MERCAPTOPURINE;
MESALAZINE;
NEUTROPHIL CYTOPLASMIC ANTIBODY;
PERINUCLEAR NEUTROPHIL CYTOPLASMIC ANTIBODY;
PROBIOTIC AGENT;
SACCHAROMYCES CEREVISIAE ANTIBODY;
STEROID;
THIOPURINE METHYLTRANSFERASE;
TIOGUANINE;
UNCLASSIFIED DRUG;
ANUS;
ARTICLE;
BLOOD TOXICITY;
CLINICAL RESEARCH;
CONTROLLED STUDY;
CROHN DISEASE;
DIAGNOSTIC TEST;
DIFFERENTIAL DIAGNOSIS;
DISEASE MARKER;
DRUG METABOLISM;
DRUG RESPONSE;
HOST PATHOGEN INTERACTION;
HUMAN;
ILEITIS;
ILEUM POUCH;
IMMUNOMODULATION;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION RISK;
INTESTINE ANASTOMOSIS;
PATHOGENESIS;
PHARMACOGENOMICS;
PRIORITY JOURNAL;
SEROLOGY;
SIDE EFFECT;
TREATMENT INDICATION;
TREATMENT OUTCOME;
ULCERATIVE COLITIS;
ENTERITIS;
IMMUNOLOGY;
HUMANS;
INFLAMMATORY BOWEL DISEASES;
SEROLOGIC TESTS;
|
|
EID: 0036584588
PISSN: 10780998
EISSN: None
Source Type: Journal
DOI: 10.1097/00054725-200205000-00012 Document Type: Article |
|
Times cited : (8)
|
|
References (9)
|
